Page last updated: 2024-08-24

repaglinide and clopidogrel

repaglinide has been researched along with clopidogrel in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Sternon, J	1
Backman, JT; Filppula, AM; Kailari, O; Neuvonen, M; Neuvonen, PJ; Niemi, M; Nyrönen, TH; Tapaninen, T; Tornio, A	1
Lin, FJ; Lin, SY; Wang, CC; Wei, Y	1
Fujii, K; Hazama, Y; Kosugi, M; Miyoshi, Y; Nagata, S; Obata, Y; Takayama, K; Uehara, Y; Yamaguchi, H; Yasuda, T	1

Reviews

2 review(s) available for repaglinide and clopidogrel

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[New drugs]. Revue medicale de Bruxelles, 2001, Volume: 22, Issue:4 Topics: Amdinocillin; Carbamates; Clopidogrel; Cyclohexanes; Drug Interactions; Humans; Hypoglycemic Agents; Nateglinide; Patient Selection; Penicillins; Phenylalanine; Piperidines; Platelet Aggregation Inhibitors; Pneumococcal Vaccines; Raloxifene Hydrochloride; Safety; Selective Estrogen Receptor Modulators; Ticlopidine	2001

Trials

1 trial(s) available for repaglinide and clopidogrel

Article	Year
Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions. Clinical pharmacology and therapeutics, 2014, Volume: 96, Issue:4 Topics: Aryl Hydrocarbon Hydroxylases; Carbamates; Catalytic Domain; Clopidogrel; Computer Simulation; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Drug Interactions; Female; Glucuronides; Humans; Hypoglycemic Agents; Male; Metabolic Detoxication, Phase II; Molecular Docking Simulation; Piperidines; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors	2014

Article

Year

Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions.

Clinical pharmacology and therapeutics, 2014, Volume: 96, Issue:4

Topics: Aryl Hydrocarbon Hydroxylases; Carbamates; Catalytic Domain; Clopidogrel; Computer Simulation; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Drug Interactions; Female; Glucuronides; Humans; Hypoglycemic Agents; Male; Metabolic Detoxication, Phase II; Molecular Docking Simulation; Piperidines; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors

2014

Other Studies

2 other study(ies) available for repaglinide and clopidogrel

Article	Year
Risk of Hypoglycemia and Concomitant Use of Repaglinide and Clopidogrel: A Population-Based Nested Case-Control Study. Clinical pharmacology and therapeutics, 2019, Volume: 106, Issue:6 Topics: Aged; Aspirin; Carbamates; Case-Control Studies; Clopidogrel; Drug Interactions; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Piperidines; Platelet Aggregation Inhibitors	2019
Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency. Internal medicine (Tokyo, Japan), 2021, Volume: 60, Issue:6 Topics: Aged; Blood Glucose; Carbamates; Clopidogrel; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Hypoglycemic Agents; Piperidines; Renal Insufficiency	2021

Article

Year

Risk of Hypoglycemia and Concomitant Use of Repaglinide and Clopidogrel: A Population-Based Nested Case-Control Study.

Clinical pharmacology and therapeutics, 2019, Volume: 106, Issue:6

Topics: Aged; Aspirin; Carbamates; Case-Control Studies; Clopidogrel; Drug Interactions; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Piperidines; Platelet Aggregation Inhibitors

2019

Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency.

Internal medicine (Tokyo, Japan), 2021, Volume: 60, Issue:6

Topics: Aged; Blood Glucose; Carbamates; Clopidogrel; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Hypoglycemic Agents; Piperidines; Renal Insufficiency

2021